Innovations in Clinical Pharmacy: Towards Optimized Patient Care

A special issue of Pharmacy (ISSN 2226-4787). This special issue belongs to the section "Pharmacy Practice and Practice-Based Research".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 1661

Special Issue Editor


E-Mail Website
Guest Editor
School of Pharmacy, University College Cork, T12 YN60 Cork, Ireland
Interests: clinical pharmacy; cancer research; health literacy; medication adherence; vaccine health
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

I am delighted to invite contribution to this Special Issue; Innovations in Clinical Pharmacy: Towards Optimized Patient Care.

Innovations can be simple or complex, can be done as an individual or as part of a team, but their aim is to enhance the patients experience. As pharmacists, we can be working in the community, hospital or any other practice setting, but we are always focused on making things better for the patient.

This innovation may involve interprofessional collaborations, as part of a multidisciplinary team or may be a unique strategy that other pharmacists can implement into their practice.

Many patients are challenged by swallowing difficulties and the subsequent modification of dosage forms is an area requiring specialist pharmacist knowledge combined with communication skills.

I am particularly interested in contribution that enhance the accessibility or acceptability of medication or medicines information, to empower patients and the public to make informed healthcare decisions.

I welcome contributions relating to health literacy, medication adherence, modification of medicines, evolving role of the pharmacist in specialist settings, e.g., oncology, vaccine uptake and acceptance, prescribing cascades or deprescribing. However, please do not hesitate to send me an abstract for consideration.

Prof. Dr. Laura Jane Sahm
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • health literacy
  • medication adherence
  • vaccines
  • cancer
  • deprescribing
  • medicines modification

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 2287 KiB  
Article
Enteral Delivery of Pravastatin Sodium Tablets: Effect of Compounding into a Liquid Form and Co-Administration of Enteral Nutrition
by Serena Logrippo, Roberta Ganzetti, Matteo Sestili, Diego Romano Perinelli, Marco Cespi and Giulia Bonacucina
Pharmacy 2024, 12(1), 32; https://doi.org/10.3390/pharmacy12010032 - 9 Feb 2024
Viewed by 1269
Abstract
Background: Compounding solid oral dosage forms into liquid preparations is a common practice for administering drug therapy to patients with swallowing difficulties. This is particularly relevant for those on enteral nutrition, where factors such as the administration procedure and co-administration of enteral nutrition [...] Read more.
Background: Compounding solid oral dosage forms into liquid preparations is a common practice for administering drug therapy to patients with swallowing difficulties. This is particularly relevant for those on enteral nutrition, where factors such as the administration procedure and co-administration of enteral nutrition play crucial roles in effective drug delivery. Due to the limited studies focused on this practice, the impact of co-administered nutrition remains unclear. Methods: Pravastatin tablets were compounded into two liquid formulations and administered through three independent tubes for ten cycles. The drug amount was quantified upstream and downstream of the tubes both with and without different (fiber content) nutritional boluses. Results: The compounding procedure did not lower the drug amount with respect to the original tablets. However, when the liquid formulation was pumped through the tubes, a statistically significant reduction in the pravastatin administered (between 4.6% and 11.3%) was observed. The co-administration of different nutritional boluses or the compounding procedure did not affect the general results. Conclusions: Pravastatin loss appears unavoidable when administered via the enteral tube. Although, in this case, the loss was of limited clinical relevance, it is important not to underestimate this phenomenon, especially with drugs having a narrow therapeutic index. Full article
(This article belongs to the Special Issue Innovations in Clinical Pharmacy: Towards Optimized Patient Care)
Show Figures

Figure 1

Back to TopTop